7 Recruiting Hepatocellular Carcinoma (HCC) Phase 2 Clinical Trials
Active phase 2 studies for hepatocellular carcinoma (hcc) enrolling across the USA. Verify eligibility and contact site coordinators.
All Hepatocellular Carcinoma (HCC) studiesPhase 2 Studies for Hepatocellular Carcinoma (HCC)
🔵 Active, Not Recruiting Phase2
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE
📍 Research Site — Aurora, Colorado
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin
📍 Zuckerberg San Francisco General Hospital (ZSFG) — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant
📍 London Health Sciences Centre — London, Ontario
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
📍 Local Institution - 0137 — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
📍 Research Facility — Birmingham, Alabama
View Study & Checklist ➔